On Monday, Atyr Pharma Inc (NASDAQ: ATYR) was 9.03% up from the session before settling in for the closing price of $2.99. A 52-week range for ATYR has been $1.08 – $3.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 436.18% over the past five years. When this article was written, the company’s average yearly earnings per share was at 5.62%. With a float of $73.81 million, this company’s outstanding shares have now reached $75.80 million.
Let’s look at the performance matrix of the company that is accounted for 59 employees. In terms of profitability, gross margin is -334.18%, operating margin of -10633.5%, and the pretax margin is -9846.26%.
Atyr Pharma Inc (ATYR) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Atyr Pharma Inc stocks. The insider ownership of Atyr Pharma Inc is 2.61%, while institutional ownership is 70.14%. The most recent insider transaction that took place on Jul 24 ’24, was worth 101,038. In this transaction Director of this company bought 52,300 shares at a rate of $1.93, taking the stock ownership to the 413,023 shares. Before that another transaction happened on Jul 22 ’24, when Company’s Director bought 41,052 for $1.74, making the entire transaction worth $71,500. This insider now owns 354,075 shares in total.
Atyr Pharma Inc (ATYR) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.2 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to 43.36% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
You can see what Atyr Pharma Inc (ATYR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 418.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.91, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.77 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Atyr Pharma Inc (NASDAQ: ATYR) saw its 5-day average volume 2.06 million, a positive change from its year-to-date volume of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 86.23%. Additionally, its Average True Range was 0.20.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 86.79%, which indicates a significant increase from 84.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.33% in the past 14 days, which was higher than the 75.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.97, while its 200-day Moving Average is $1.81. Nevertheless, the first resistance level for the watch stands at $3.55 in the near term. At $3.83, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.13. If the price goes on to break the first support level at $2.97, it is likely to go to the next support level at $2.67. Assuming the price breaks the second support level, the third support level stands at $2.39.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are 69,011K outstanding shares of the company, which has a market capitalization of 247.11 million. As of now, sales total 350 K while income totals -50,390 K. Its latest quarter income was 240 K while its last quarter net income were -15,490 K.
